Amelioration of rotenone-induced Parkinson's disease; comparing therapeutic role of erythropoietin versus low-level laser activation of mesenchymal stem cells (an in-vivo and in-vitro study)

References

• Abdelwahab S, Elsebay SAG, Fouli Gaber M, Abdel-Hafez SMN. 2021. Comparative study between bone marrow mesenchymal stem cell and their conditioned medium in the treatment of rat model of parkinsonism. J Cell Physiol. 236(1):440–457. doi:10.1002/jcp.29872.
   PubMed Web of Science ®Google Scholar
• Apostolova I, Irintchev A, Schachner M. 2006. Tenascin-R restricts posttraumatic remodeling of motoneuron innervation and functional recovery after spinal cord injury in adult mice. J Neurosci. 26(30):7849–7859. doi:10.1523/JNEUROSCI.1526-06.2006.
   PubMed Web of Science ®Google Scholar
• Baglio SR, Pegtel DM, Baldini N. 2012. Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol. 3:359. doi:10.3389/fphys.2012.00359.
   PubMed Web of Science ®Google Scholar
• Benkler C, Barhum Y, Ben-Zur T, Offen D. 2016. Multifactorial gene therapy enhancing the glutamate uptake system and reducing oxidative stress delays symptom onset and prolongs survival in the SOD1-G93A ALS mouse model. J Mol Neurosci. 58(1):46–358. doi:10.1007/s12031-015-0695-2.
   PubMed Web of Science ®Google Scholar
• Bittira B, Shum-Tim D, Al-Khaldi A, Chiu RC. 2003. Mobilization and homing of bone marrow stromal cells in myocardial infarction. Eur J Cardiothorac Surg. 24(3):393–398. doi:10.1016/S1010-7940(03)00325-7.
   PubMed Web of Science ®Google Scholar
• Cai WF, Liu GS, Wang L, Paul C, Wen ZL, Wang Y. 2016. Repair injured heart by regulating cardiac regenerative signals. Stem Cells Int. 2016:6193419.
   PubMed Web of Science ®Google Scholar
• Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, Greenamyre JT. 2009. A highly reproducible rotenone model of Parkinson's disease. Neurobiol Dis. 34(2):279–290. doi:10.1016/j.nbd.2009.01.016.
   PubMed Web of Science ®Google Scholar
• Capitelli CS, Lopes CS, Alves AC, Barbiero J, Oliveira LF, da Silva VJD, Vital MABF. 2014. Opposite effects of bone marrow-derived cells transplantation in MPTP-rat model of Parkinson's disease: a comparison study of mononuclear and mesenchymal stem cells. Int J Med Sci. 11(10):1049. doi:10.7150/ijms.8182.
   PubMed Web of Science ®Google Scholar
• Castrén E, Antila H. 2017. Neuronal plasticity and neurotrophic factors in drug responses. Mol Psychiatry. 22(8):1085–1095. doi:10.1038/mp.2017.61.
   PubMed Web of Science ®Google Scholar
• Chan YH. 2003. Biostatistics102: quantitative data – parametric & Non-parametric tests. Singapore Med J. 44(8):391–396.
   PubMedGoogle Scholar
• Chen J, Li C, Liu W, Yan B, Hu X, Yang F. 2019. MiRNA-155 silencing reduces sciatic nerve injury in diabetic peripheral neuropathy. J Mol Endocrinol. 63(3):227–238. doi:10.1530/JME-19-0067.
   PubMed Web of Science ®Google Scholar
• Chen Y, Shen J, Ke K, Gu X. 2020. Clinical potential and current progress of mesenchymal stem cells for Parkinson’s disease: a systematic review. Neurol Sci. 41(5):1051–1061.
   PubMed Web of Science ®Google Scholar
• Chi H, Guan Y, Li F, Chen Z. 2019. The effect of human umbilical cord mesenchymal stromal cells in protection of dopaminergic neurons from apoptosis by reducing oxidative stress in the early stage of a 6-OHDA-induced Parkinson’s disease model. Cell Transplant. 28(1_suppl):87S–99S. doi:10.1177/0963689719891134.
   PubMed Web of Science ®Google Scholar
• Crawley J. 1999. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests1Published on the world wide Web on 2 December 1998.1. Brain Res. 835(1):18–26. doi:10.1016/S0006-8993(98)01258-X.
   PubMed Web of Science ®Google Scholar
• Dias V, Junn E, Mouradian MM. 2013. The role of oxidative stress in Parkinson's disease. J Parkinsons Dis. 3(4):461–491. doi:10.3233/JPD-130230.
   PubMedGoogle Scholar
• Dorsey ER, Bloem BR. 2018. The Parkinson pandemic—a call to action. JAMA Neurol. 75(1):9–10. doi:10.1001/jamaneurol.2017.3299.
   PubMed Web of Science ®Google Scholar
• Duan W, Chen Y, Wang XR. 2018. MicroRNA-155 contributes to the occurrence of epilepsy through the PI3 K/Akt/mTOR signaling pathway. Int J Mol Med. 42(3):1577–1584.
   PubMed Web of Science ®Google Scholar
• El Asar HM, Mohammed EA, Aboulhoda BE, Emam HY, Imam AAA. 2019. Selenium protection against mercury neurotoxicity: modulation of apoptosis and autophagy in the anterior pituitary. Life Sci. 231:116578. doi:10.1016/j.lfs.2019.116578.
   PubMed Web of Science ®Google Scholar
• Fekrazad R, Eslaminejad MB, Shayan AM, Kalhori KA, Abbas FM, Taghiyar L, Pedram MS, Ghuchani MS. 2016. Effects of photobiomodulation and mesenchymal stem cells on articular cartilage defects in a rabbit model. Photomed Laser Surg. 34(11):543–116549. doi:10.1089/pho.2015.4028.
   PubMed Web of Science ®Google Scholar
• Fleming SM, Salcedo J, Fernagut PO, Rockenstein E, Masliah E, Levine MS, Chesselet MF. 2004. Early and progressive sensorimotor anomalies in mice overexpressing wild-type human α-synuclein. J Neurosci. 24(42):9434–9440. doi:10.1523/JNEUROSCI.3080-04.2004.
   PubMed Web of Science ®Google Scholar
• Ghasemi M, Sadeghipour H, Poorheidari G, Dehpour AR. 2009. A role for nitrergic system in the antidepressant-like effects of chronic lithium treatment in the mouse forced swimming test. Behav Brain Res. 200(1):76–82. doi:10.1016/j.bbr.2008.12.032.
   PubMed Web of Science ®Google Scholar
• Glavaski-Joksimovic A, Bohn MC. 2013. Mesenchymal stem cells and neuroregeneration in Parkinson's disease. Exp Neurol. 247:25–38. doi:10.1016/j.expneurol.2013.03.016.
   PubMed Web of Science ®Google Scholar
• Gutiérrez D, Rouabhia M, Ortiz J, Gaviria D, Alfonso C, Muñoz A, Inostroza C. 2021. Low-Level laser irradiation promotes proliferation and differentiation on apical papilla stem cells. J Lasers Med Sci. doi:10.34172/jlms.2021.75.
   PubMed Web of Science ®Google Scholar
• Jankovic J, Aguilar LG. 2008. Current approaches to the treatment of Parkinson’s disease. Neuropsychiatr Dis Treat. 4(4):743–757. doi:10.2147/NDT.S2006.
   PubMedGoogle Scholar
• Johnson ME, Bobrovskaya L. 2015. An update on the rotenone models of Parkinson's disease: their ability to reproduce the features of clinical disease and model gene–environment interactions. Neurotoxicology. 46:101–116. doi:10.1016/j.neuro.2014.12.002.
   PubMed Web of Science ®Google Scholar
• Li L, Guan Q, Dai S, Wei W, Zhang Y. 2017. Integrin β1 increases stem cell survival and cardiac function after myocardial infarction. Front Pharmacol. 8:135.
   PubMed Web of Science ®Google Scholar
• Liu J, Narasimhan P, Yu F, Chan PH. 2005. Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin. Stroke. 36(6):1264–1269. doi:10.1161/01.STR.0000166180.91042.02.
   PubMed Web of Science ®Google Scholar
• Liu NM, Tian J, Wang WW, Han GF, Cheng J, Huang J, Zhang JY. 2013. Effect of erythropoietin on mesenchymal stem cell differentiation and secretion in vitro in an acute kidney injury microenvironment. Genet Mol Res. 12(4):6477–6487. doi:10.4238/2013.February.28.14.
   PubMed Web of Science ®Google Scholar
• Lo Furno D, Mannino G, Giuffrida R. 2018. Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases. J Cell Physiol. 233(5):3982–3999. doi:10.1002/jcp.26192.
   PubMed Web of Science ®Google Scholar
• Lykov AP, Surovtseva MA, Kim II, et al. 2020. Effect of erythropoietin on morphofunctional properties of mesenchymal stem cells. Bull Exp Biol Med. 170:164–170. doi:10.1007/s10517-020-05024-z.
   PubMed Web of Science ®Google Scholar
• Mitra S, Chakrabarti N, Dutta SS, Ray S, Bhattacharya P, Sinha P, Bhattacharyya A. 2015. Gender-specific brain regional variation of neurons, endogenous estrogen, neuroinflammation and glial cells during rotenone-induced mouse model of Parkinson's disease. Neuroscience. 292:46–70. doi:10.1016/j.neuroscience.2014.12.052.
   PubMed Web of Science ®Google Scholar
• Pagani FD, DerSimonian H, Zawadzka A, Wetzel K. 2003. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. J Am Coll Cardiol. 41(5):879–888. doi:10.1016/S0735-1097(03)00081-0.
   PubMed Web of Science ®Google Scholar
• Palasz E, Wysocka A, Gasiorowska A, Chalimoniuk M, Niewiadomski W, Niewiadomska G. 2020. BDNF as a promising therapeutic agent in Parkinson’s disease. Int J Mol Sci. 21(3):1170. doi:10.3390/ijms21031170.
   PubMed Web of Science ®Google Scholar
• Rial D, Castro AA, Machado N, Garção P, Gonçalves FQ, Silva HB, Tomé AR, Köfalvi A, et al. 2014. Behavioral phenotyping of parkin-deficient mice: looking for early preclinical features of Parkinson's disease. PloS one. 9(12):e114216. doi:10.1371/journal.pone.0114216.
   PubMed Web of Science ®Google Scholar
• Sayed SY, Salem SI, Abdallah AN, Khalil GM, Mohammed FF. 2019. Clinicopathological studies on the use of laser-activated adipose-derived stromal vascular fraction in treatment of streptozotocin-induced diabetes in rats. Comp Clin Path. 28(5):1515–1526. doi:10.1007/s00580-019-03008-8.
   Google Scholar
• Seo Y, Yang SR, Jee MK, Joo EK, Roh KH, Seo MS, Han TH, Lee SY, et al. 2011. Human umbilical cord blood-derived mesenchymal stem cells protect against neuronal cell death and ameliorate motor deficits in niemann pick type C1 mice. Cell Transplant. 20(7):1033–1047. doi:10.3727/096368910X545086.
   PubMed Web of Science ®Google Scholar
• ShamsEldeen AM, Ashour H, Shoukry HS, Fadel M, Kamar SS, Aabdelbaset M, Rashed LA, Ammar HI. 2019. Combined treatment with systemic resveratrol and resveratrol preconditioned mesenchymal stem cells, maximizes antifibrotic action in diabetic cardiomyopathy. J Cell Physiol. 234(7):10942–10963. doi:10.1002/jcp.27947.
   PubMed Web of Science ®Google Scholar
• Shao QH, Chen Y, Li FF, Wang S, Zhang XL, Yuan YH, Chen NH. 2019. TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson’s disease. Acta Pharmacol Sin. 40(12):1503–1512. doi:10.1038/s41401-019-0280-2.
   PubMed Web of Science ®Google Scholar
• Sharma S, Raj K, Singh S. 2020. Neuroprotective effect of quercetin in combination with piperine against rotenone- and iron supplement–induced Parkinson’s disease in experimental rats. Neurotox Res. 37(1):198–209. doi:10.1007/s12640-019-00120-z.
   PubMed Web of Science ®Google Scholar
• Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, et al. 2003. Mechanism of toxicity in rotenone models of Parkinson's disease. J Neurosci. 23(34):10756–10764. doi:10.1523/JNEUROSCI.23-34-10756.2003.
   PubMed Web of Science ®Google Scholar
• Soleimani M, Abbasnia E, Fathi M, Sahraei H, Fathi Y, Kaka G. 2012. The effects of low-level laser irradiation on differentiation and proliferation of human bone marrow mesenchymal stem cells into neurons and osteoblasts—an in vitro study. Lasers Med Sci. 27(2):423–430. doi:10.1007/s10103-011-0930-1.
   PubMed Web of Science ®Google Scholar
• Somoza R, Juri C, Baes M, Wyneken U, Rubio FJ. 2010. Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease. Biol Blood Marrow Transplant. 16(11):1530–1540. doi:10.1016/j.bbmt.2010.06.006.
   PubMed Web of Science ®Google Scholar
• Staffoli S, Romeo U, Amorim RNS, Migliau G, Palaia G, Resende L, Polimeni A. 2017. The effects of low level laser irradiation on proliferation of human dental pulp: a narrative review. Clin Ter. 168(5):e320–e326.
   PubMedGoogle Scholar
• Sun L, Li D, Song K, Wei J, Yao S, Li Z, Su X, Ju X, Chao L, Deny X, et al. 2017. Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness. Sci Rep. 7(1):1–13. doi:10.1038/s41598-016-0028-x.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang H, Lu J, Feng Z, Liu Z, Song H, Wang H, Zhou Y, Xu J. 2020. Erythropoietin-modified mesenchymal stem cells enhance anti-fibrosis efficacy in mouse liver fibrosis model. Tissue Engineering and Regenerative Medicine. 17(5):683–693. doi:10.1007/s13770-020-00276-2.
   PubMed Web of Science ®Google Scholar
• Westin JE, Andersson M, Lundblad M, Cenci MA. 2001. Persistent changes in striatal gene expression induced by long-terml-DOPA treatment in a rat model of Parkinson's disease. Eur J Neurosci. 14(7):1171–1176. doi:10.1046/j.0953-816x.2001.01743.x.
   PubMed Web of Science ®Google Scholar
• Wu S, FitzGerald KT, Giordano J. 2018. On the viability and potential value of stem cells for repair and treatment of central neurotrauma: overview and speculations. Front Neurol. 9:602. doi:10.3389/fneur.2018.00602.
   PubMed Web of Science ®Google Scholar
• Xiong N, Long X, Xiong J, Jia M, Chen C, Huang J, Ghoorah D, Kong X, Lin Z, Wang T. 2012. Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson’s disease models. Crit Rev Toxicol. 42(7):613–632. doi:10.3109/10408444.2012.680431.
   PubMed Web of Science ®Google Scholar
• Zhou S, Liu YG, Zhang Y, Hu JM, Liu D, Chen H, Li M, Guo Y, Fan LP, et al. 2018. Bone mesenchymal stem cells pretreated with erythropoietin enhance the effect to ameliorate cyclosporine A-induced nephrotoxicity in rats. J Cell Biochem. 119(10):8220–8232. doi:10.1002/jcb.26833.
   PubMed Web of Science ®Google Scholar